logo

Veru Inc. (VERU)



Trade VERU now with
  Date
  Headline
6/7/2022 6:45:29 AM Veru Submits EUA Application To U.S. FDA For Sabizabulin For Hospitalized COVID-19 Patients At High Risk For ARDS
4/11/2022 6:36:37 AM Veru Announces Positive Results From Interim Phase 3 COVID-19 Clinical Trial Of Oral Sabizabulin
2/9/2022 6:38:08 AM Veru Q1 Net Loss $6.4 Mln Or $0.08/Shr Vs Income $17.2 Mln Or $0.25/Shr Last Year
2/1/2022 8:40:56 AM Veru Enters Clinical Collaboration And Supply Deal With Lilly To Evaluate Enobosarm With Verzenio In ENABLAR-2 Trial
8/12/2021 6:49:47 AM Veru Q3 Net Loss $2.7 Mln Or $0.03/Shr Vs $3.0 Mln Or $0.05/Shr Last Eyar
6/10/2021 8:36:29 AM Veru Enrolls First Patient In Phase 2 Clinical Trial Of VERU-100 For Hormone Sensitive Advanced Prostate Cancer
3/8/2021 8:36:03 AM Veru Explores Strategic Alternatives For Its Legacy Female Health Business
2/23/2021 8:50:25 AM Veru Submits New Drug Application With FDA For Proprietary TADFIN For Benign Prostatic Hyperplasia